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Abstract
Objective: We studied the combined effects of wholegrain, fish and bilberries on serum metabolic profile and lipid transfer
protein activities in subjects with the metabolic syndrome.
Methods: Altogether 131 subjects (40–70 y, BMI 26–39 kg/m ) with impaired glucose metabolism and features of the2
metabolic syndrome were randomized into three groups with 12-week periods according to a parallel study design. They
consumed either: a) wholegrain and low postprandial insulin response grain products, fatty fish 3 times a week, and
bilberries 3 portions per day (HealthyDiet), b) wholegrain and low postprandial insulin response grain products (WGED), or
c) refined wheat breads as cereal products (Control). Altogether 106 subjects completed the study. Serum metabolic profile
was studied using an NMR-based platform providing information on lipoprotein subclasses and lipids as well as low-
molecular-weight metabolites.
Results: There were no significant differences in clinical characteristics between the groups at baseline or at the end of the
intervention. Mixed model analyses revealed significant changes in lipid metabolites in the HealthyDiet group during the
intervention compared to the Control group. All changes reflected increased polyunsaturation in plasma fatty acids,
especially in n-3 PUFAs, while n-6 and n-7 fatty acids decreased. According to tertiles of changes in fish intake, a greater
increase of fish intake was associated with increased concentration of large HDL particles, larger average diameter of HDL
particles, and increased concentrations of large HDL lipid components, even though total levels of HDL cholesterol
remained stable.
Conclusions: The results suggest that consumption of diet rich in whole grain, bilberries and especially fatty fish causes
changes in HDL particles shifting their subclass distribution toward larger particles. These changes may be related to known
protective functions of HDL such as reverse cholesterol transport and could partly explain the known protective effects of
fish consumption against atherosclerosis.
The study was registered at ClinicalTrials.gov NCT00573781.
Citation: Lankinen M, Kolehmainen M, Ja¨a¨skela¨inen T, Paananen J, Joukamo L, et al. (2014) Effects of Whole Grain, Fish and Bilberries on Serum Metabolic Profile
and Lipid Transfer Protein Activities: A Randomized Trial (Sysdimet). PLoS ONE 9(2): e90352. doi:10.1371/journal.pone.0090352
Editor: Heiner K. Berthold, Bielefeld Evangelical Hospital, Germany
Received September 2, 2013; Accepted January 26, 2014; Published February 28, 2014
Copyright:  2014 Lankinen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by: the Academy of Finland (grant numbers 117844 and 118590 to MU, 117996 for MO, 131460 to KP, 137870 to PS, and
257545 to MJ), European Commission in the Communities 6th Framework Programme Project HEALTHGRAIN (FOOD-CT-2005-514008 to HM and KP), The Kuopio
University Hospital (grant numbers 5106, 5168 and 5254 to MU), Sigrid Juse´lius Foundation (MAK), TEKES – the Finnish Funding Agency for Technology and
Innovation (MAK), the Strategic Research Funding from the University of Oulu (MAK). The Finnish Diabetes Research Foundation, Nordic Centre of Excellence on
Systems Biology in Controlled Dietary Intervention and Cohort Studies (SYSDIET, 070014), Fazer bakeries Oy, Vaasan & Vaasan Oy, KE Leipa¨ Oy, Leipomo Ruista¨hka¨,
Leipomo Koskelonseutu, Raisio Oyj, Pakkasmarja Oy and Joswola Oy. The funders had no role in study design, data collection and analysis, decision to publish or
preparation of the manuscript.
Competing Interests: AJK, PS and MAK are shareholders of Brainshake Ltd, a startup company offering NMR-based metabolite profiling. We also received food
products, which were delivered to the participants in all three study groups, from commercial sources: Fazer Bakeries, Vaasa & Vaasan, Ke Leipa¨, Leipomo
Ruista¨hka¨, Leipomo Koskelonseuru, Raisio Oyj, Pakkasmarja Oy and Joswola Oy. This does not alter our adherence to all the PLOS ONE policies on sharing data and
materials. Other authors have no conflict of interest.
* E-mail: maria.lankinen@uef.fi
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e90352
 
Trial Registration:  
Introduction
Wholegrain, fish, and polyphenol rich foods, such as berries, are
known to have beneficial effects on human health [1–3]. These
food items are also part of the Nordic diet, which has recently
raised a great interest. In an observational study, healthy Nordic
food pattern has been shown to be associated with reduced
mortality in adults [4]. In intervention studies improvements in
cardiovascular and diabetic risk markers, especially low-grade
inflammation, in high risk individuals have been reported [5–7].
Overall, nutritional studies are shifting increasingly their focus
from studying single nutrients or foods on the exploration of the
whole dietary pattern. The Mediterranean diet is probably the
best-known dietary pattern and has long been related to improved
health and prevention of e.g. cardiovascular diseases (CVD) and
type 2 diabetes [8–10].
Epidemiological evidence is strong concerning the beneficial
effects of consumption of fish on the prevention of coronary heart
disease (CHD) progression and mortality [11,12]. The hypotrigly-
ceridemic effect of fish oil is also well documented, but the
evidence has been obtained from trials using fish oil supplements
and in larger amounts than currently recommended [13,14].
Instead, there is no evidence of a secondary preventive effect of n-3
fatty acid supplements against overall cardiovascular events among
patients with a history of cardiovascular disease [15]. The effect on
glucose and insulin metabolism has been inconsistent, but possible
adverse effects on glucose metabolism related to especially higher
doses may be compensated by improved serum triglyceride
concentration in diabetic subjects [14,16,17]. Recent controlled
experimental studies have focused on the effects of supplemental
long chain n-3 polyunsaturated fatty acids rather than the effects of
dietary fish.
The use of metabolomics in nutrition-related research has made
a significant impact on assessing novel biomarkers of dietary intake
as well as analyses of intervention studies [18]. Mass spectrometry
and proton nuclear magnetic resonance (NMR) spectroscopy are
the two key experimental technologies in the field. NMR
spectroscopy could provide information on lipoprotein subclass
distribution and lipoprotein particle concentrations, low-molecu-
lar-weight metabolites as well as detailed molecular information on
serum lipids [19,20]. It is suggested that besides the measurement
of standard lipids, including total cholesterol, LDL cholesterol and
HDL cholesterol concentrations, the measurement of specific
HDL subclasses might help in evaluation of the risk of
cardiovascular events [21]. Increased concentration of large
HDL particles has inverse association with the risk of coronary
artery disease, while small HDL particles appear to be associated
with increased risk [21,22]. Lipid transfer proteins phospholipid
transfer protein (PLTP) and cholesterol ester transfer protein
(CETP) are among factors which modify HDL composition and
also affect efficiency of HDL-mediated reverse cholesterol
transport [23–25]. HDL associated enzyme paraoxonase 1
(PON1) also is an important factor regulating anti-oxidative
processes of lipoprotein particles, mainly LDL and HDL [26].
Few studies so far examined cross-sectional association between
nutrients and lipoprotein subclasses suggest that alcohol, disac-
charides, and n-3 PUFAs are associated with serum lipoprotein
subclass distribution [27–30]. Controlled trials have focused on n-
3 PUFAs, mainly using supplements. Most studies investigating the
effects of n-3 PUFAs or fatty fish on HDL particle subspecies have
reported increases in large HDL particles and/or decreases of
small HDL particles [31]. In our pilot study, fatty fish intake at
least 4 times per week increased HDL particle size [32].
Considering whole dietary patterns, positive associations have
been reported between a high-fat, high-sucrose and low fiber
dietary pattern (junk food) and concentrations of serum triglycer-
ides (Tg) and small dense HDL particles, larger Tg-enriched
VLDL particles and small dense LDL particles [33].
We have previously shown that a diet rich in whole grain and
low insulin response grain products, fatty fish and berries alter
plasma lipidomic profile and improves glucose metabolism and
markers of endothelial function and inflammation [6,34]. In the
present secondary analyses of the same trial, we take the advantage
of the comprehensive information provided by the new serum
NMR-based metabolomics platform and examine the combined
effects of these food items on the systemic metabolic profiles and
lipid transfer protein activities in subjects with the metabolic
syndrome. Furthermore, we study the associations between the
changes in fish intake and changes in variables related to large
HDL particles, and cross-sectional correlations between the lipid
transfer protein activities and variables related to large HDL
particles, and between average diameter of HDL and LDL
particles and serum Tg.
Materials and Methods
Ethics statement
The participants volunteered to the study and gave their written
informed consent. The study plan was approved by the Research
Ethics Committee, Hospital District of Northern Savo. The
intervention was performed in accordance of Helsinki Declaration.
The study was registered at ClinicalTrials.gov NCT00573781.
The trial was registered after participants’ recruitment began. The
registration was delayed, because of the fact that the procedure of
trial registration had just began to be a common practice at that
time (2007), and we were not aware of the details related to the
time limits. However, we did not start recruitment before the study
plan was approved by the Research Ethics Committee. The trial
was registered before the intervention began.
The protocol for this trial and completed CONSORT checklist
are available as supporting information; See Checklist S1 and
Protocol S1. The data is available from authors.
Subjects
Altogether 131free-living subjects of Caucasian origin were
recruited into a 12-week parallel controlled dietary intervention
trial via advertisements in the local newspaper in Kuopio area.
The trial was conducted at the Department of Clinical Nutrition,
University of Eastern Finland (Kuopio, Finland). Recruitment and
screening were done during October 2007 - November 2008, and
intervention periods were carried out during January 2008 - June
2009. The inclusion criteria were age 40–70 years, impaired
glucose metabolism (fP-gluc 5.6–6.9 mmol/l or in OGTT 2 hour
P-gluc 7.8–11.0 mmol/l) and two of the following: BMI 26–
39 kg/m2, waist circumference .102 cm in men and .88 cm in
women, serum Tg .1.7 mmol/l, HDL ,1.0 mmol/l in men and
,1.3 mmol/l in women or blood pressure $130 or $85 mmHg
(NCEP Adult Treatment Panel III, 2001). After a baseline period
of two weeks with unchanged diet and lifestyle habits, the subjects
were randomized by study nurse into three groups; HealthyDiet,
Wholegrain Enriched Diet (WGED) or Control. The randomiza-
tion was conducted based on a randomization table by matching
the subjects according to gender and medians of age, fP-gluc and
BMI of the study population at screening so that from every
division of randomizing factors (gender-.age-.BMI-.fP-glucose)
it was possible to end up to any of the three study groups. The
matching produced equal amounts of certain strata classes among
the groups. Altogether 106 subjects completed the study (Figure 1).
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Serum samples for a high-throughput 1H-NMR analyses were
available from 105 participants. The drop outs did not differ in
clinical characteristics except they were younger than the
completers (5568 vs. 5967 years, mean 6 SD, p= 0.023).
Baseline characteristics of the subjects are presented in Table 1.
Of all subjects, 86% had at least one medication. Subjects were
asked to continue their medication unchanged throughout the
study. Of all subjects, 27% used statins. The use of statins or other
medication did not differ between the groups. Detailed informa-
tion about the medication of the participants has been reported
earlier [34].
Diets
In the HealthyDiet group (n= 37), the subjects replaced their
habitual grain products with whole grain breads and a bread with
low postprandial insulin response as previously reported [34]. In
brief, these products covered 20–25% of total energy intake and
were delivered to the subjects. The fiber contents of the breads
were 6.9% (endosperm rye bread), 6.4% (wholegrain wheat bread)
and 10–14% (commercial whole grain rye breads). One portion of
habitually used grain product, e.g. a slice of low fiber wheat bread,
was allowed daily to increase compliance. Pasta with the fiber
content of 6% was delivered as well and it was instructed to be
consumed at the dose equal to 3.5 deciliter of uncooked pasta per
week. The subjects were instructed to eat fatty fish (a´ 100–150 g)
Figure 1. Flow chart of the study. Adapted from De Mello et al [6].
doi:10.1371/journal.pone.0090352.g001
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three times a week. Fish was reimbursed to the subjects. Bilberries
were instructed to be consumed three portions per day (one
portion corresponding to 100 g of fresh bilberries). Bilberries were
delivered as whole frozen berries, frozen berry pure and berry
powder made of whole berries without added sugar. Other berries
were allowed to be consumed 3–4 portions (a´ #1 dl) per week.
In the WGED group (n= 34) the subjects consumed the same
grain products as in the HealthyDiet group. In addition, the
subjects could voluntarily have a wholegrain oat snack (8–8.5%
dietary fiber) 1 portion per day. Eating habits regarding fish and
berries were asked to be kept unchanged.
In the Control group (n= 35) the subjects replaced their
habitually used grain products with refined wheat breads (dietary
fiber 3–4.3 g/100 g) and other low fiber products (,6% dietary
fiber) which were delivered to the subjects. Maximum 1–2 portions
of rye products were allowed per day. Bilberries were not allowed
and other berries were allowed maximum 3–4 portions per week.
A fish meal was allowed not more than once a week.
Other eating and lifestyle habits were asked to be kept
unchanged. Alcohol use, physical exercise and medications were
asked at screening, in the beginning and at the end of the study
using a structured questionnaire. Dietary intake was monitored by
4-d food records which were kept during the run in period and
three times during the intervention period at the 3rd, 7th and 11th
week of the intervention. The recording dates were given by the
study personnel and were either from Wednesday to Saturday or
from Sunday to Wednesday. NutricaH dietary intake analysis
software (v. 2.5) was used for calculations. It is based on Finnish
food composition analyses and international food composition
tables. In addition to the food records, the subjects in all groups
kept consumption records regarding the intake of fish, grain
products and berries throughout the intervention to ensure
compliance. These records were checked each time the subjects
reported to the study center (every 1 to 2 weeks). Besides the daily
records, the intake of fish was calculated manually based on 4-d
food records.
Biochemical analyses
Fasting samples for biochemical analyses were drawn from an
antecubital vein. Methods for an oral glucose tolerance test
(OGTT), plasma glucose, serum insulin, serum cholesterol and
serum Apo A-1 and ApoB100 analyses are described in
supplementary text (Method S1).
Serum NMR Metabolomics
We applied proton NMR spectroscopy to determine the serum
metabolome via 3 different molecular windows [19,20]. These
windows provide information on 14 lipoprotein subclasses and
lipoprotein particle concentrations (LIPO), low-molecular-weight
metabolites such as amino acids, 3-hydroxybutyrate, and creati-
nine (LMWM), and detailed molecular information on serum
lipids including free and esterified cholesterol, sphingomyelin,
saturation degree and v-3 fatty acids (LIPID). The methodology
provides information on .100 primary metabolic measures and
multiple derived variables with clear biochemical interpretation
and significance [20,35]. The LIPO+LMWM data are run from
native serum samples in the same experiment and the LIPID from
the lipid extracts afterwards. The experimental protocol including
sample preparation and NMR spectroscopy are described in detail
in Inouye et al. [36]. The definition of the lipoprotein subclasses is
as follows: chylomicrons and largest VLDL particles (average
particle diameter at least 75 nm); five different VLDL subclasses:
very large VLDL (average particle diameter of 64.0 nm), large
VLDL (53.6 nm), medium VLDL (44.5 nm), small VLDL (36.8
nm), and very small VLDL (31.3 nm); intermediate-density
lipoprotein (IDL) (28.6 nm); three LDL subclasses: large LDL
Table 1. Clinical characteristics at baseline and at the end of the intervention period (mean 6 SD).
HealthyDiet n = 37 WGED n = 34 Control n = 35
0 wk 12 wk p 1 FDR p 1 0 wk 12 wk p 1 FDR p 1 0 wk 12 wk
Body mass index (kg/m2) 31.163.6 30.963.4 0.860 0.966 31.463.4 31.463.4 0.171 0.675 31.063.6 31.263.7
Waist circumference (cm) 105.669.5 105.069.1 0.008 0.091 106.3611.1 105.9611.4 0.034 0.406 105.8610.0 106.369.8
Systolic blood pressure (mmHg)137613 132613 0.453 0.833 135616 133615 0.453 0.805 139612 135613
Diastolic blood pressure
(mmHg)
8967 8667 0.596 0.833 8668 8467 0.592 0.833 8867 8666
Serum total cholesterol (mmol/l)5.160.9 5.260.8 0.396 0.793 5.161.0 5.361.1 0.160 0.675 5.461.0 5.461.0
LDL cholesterol (mmol/l) 3.160.7 3.160.7 0.804 0.953 3.260.8 3.260.9 0.334 0.712 3.460.8 3.460.8
HDL cholesterol (mmol/l) 1.360.3 1.360.3 0.966 0.966 1.260.4 1.260.4 0.919 0.966 1.360.3 1.360.3
Serum triglycerides (mmol/l) 1.660.6 1.760.8 0.250 0.712 1.560.8 1.761.0 0.951 0.966 1.560.8 1.660.7
Serum ApoA-1 (g/l) 1.560.2 1.560.2 0.673 0.847 1.460.3 1.460.3 0.706 0.847 1.460.2 1.460.2
Serum ApoB100 (g/l) 1.160.2 1.160.2 0.867 0.867 1.160.3 1.160.3 0.487 0.847 1.160.3 1.160.3
ApoB100/Apo A-1 0.7260.17 0.7160.16 0.570 0.847 0.7960.21 0.7760.19 0.671 0.847 0.8160.22 0.7960.23
Fasting plasma glucose (mmol/l)6.160.5 6.160.5 0.728 0.932 6.160.4 6.160.5 0.506 0.833 6.260.5 6.260.5
2-h plasma glucose (mmol/l) 6.761.7 6.061.8 0.099 0.530 6.661.6 6.161.9 0.211 0.675 6.861.9 6.762.2
Serum insulin (mU/l) 11.765.9 12.566.3 0.624 0.833 12.066.2 13.768.0 0.316 0.712 13.066.7 13.266.3
PLTP activity (nmol/ml/h) 728861686 724961560 0.750 0.947 748961958 733961609 0.947 0.947 698561353 692161522
CETP activity (nmol/ml/h) 25.866.9 25.466.9 0.607 0.947 24.966.3 25.166.0 0.719 0.947 25.967.4 25.866.9
PON-1 activity (mmol/min) 26.6624.0 25.3621.7 0.890 0.947 29.0624.4 27.8623.4 0.881 0.947 21.3616.0 20.4614.1
1Based on a mixed model comparison, where the interaction of time and group compared to Controls (time*group) is analyzed.
doi:10.1371/journal.pone.0090352.t001
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(25.5 nm), medium LDL (23.0 nm), and small LDL (18.7 nm); and
four HDL subclasses: very large HDL (14.3 nm), large HDL (12.1
nm), medium HDL (10.9 nm), and small HDL (8.7 nm). The
following components of the lipoprotein particles were quantified:
phospholipids, Tg, cholesterol, free cholesterol, and cholesterol
esters. Due to resolution and concentration issues all of these
components are not available for every subclass [37]. The
complete list of quantified metabolic measures is given in
Supplemental Table S1. This quantitative platform has recently
been applied in various large-scale epidemiological and genetic
studies [35–40]. Serum samples for NMR spectroscopy were
available at baseline and at the end of the intervention from 105
participants. Thus 210 samples were originally processed, but 12
samples were lost due to experimental problems.
PLTP, CETP and PON1
Radiometric methods were used to analyze CETP [41] and
PLTP activities [42]. Serum PON1 activity was measured using
paraoxon as a substrate [43].
Statistical analyses
Based on primary aim of seeing changes in glucose metabolism,
the power calculations were calculated based on fasting glucose.
By using test significance a-level 0.05, 80% power, SD 0.4665 for
variability, aim to see 5% difference between the groups in fasting
glucose and power analysis method for two-sample t-test, the
appropriate sample size was 37 per group. Statistical analyses were
performed using the IBM SPSS statistical software (v. 19, SPSS
Inc., Chicago, IL), R Project for Statistical Computing version
2.7.2 [44] and nlme R-package version 3.1–96 [45]. Linear mixed-
effect models were used to analyse group differences in the
baseline and during the intervention. Quantitative dependent
variables were transformed to base-10 logarithmic scale to account
for non-normal distributions. Selected confounding phenotypes
(gender, age, fasting glucose, BMI, cholesterol lowering medica-
tion, diuretic medication and smoking, were included in the
models as covariates when studying changes in the NMR-based
metabolic measures and subject identifiers were included as a
grouping random effect. Interaction term between group and
intervention time-point (before or after intervention) was used to
examine group related changes during the intervention. Control
group was used as a reference group when comparing group
differences. Benjamini–Hochberg false discovery rate (FDR) was
used to adjust the metabolomics measures and dietary intake
results for multiple comparisons [46]. Adjustment was done by one
treatment effect at a time and in clinically relevant sets. FDR-
adjusted p-value # 0.05 was considered as statistically significant.
All these analyses are secondary though aimed to be done in the
original study protocol. The primary aim of the study was to
examine effects on glucose metabolism [6,34].
Associations between the changes in fish intake and changes in
variables related to large HDL particles were tested using analyses
of covariance (ANCOVA). Intervention group, age, gender, BMI
and fasting glucose were included into models. Analyses were
performed using standardized variables. Differences between the
fish intake tertiles were tested using one-way ANOVA and
Bonferroni post hoc comparisons. Baseline associations were
studied applying linear regression model including age, gender,
BMI and fasting glucose into models.
Results
Clinical characteristics
The gender and age distributions of the study subjects were
similar in all three groups [6,34]. The average age was 5867,
5868 and 5967 years, and the gender distribution (male/female)
was 17/20, 17/17 and 18/17 in the HealthyDiet, WGED and
Control group, respectively. Table 1 shows the clinical character-
istics at baseline and at the end of the intervention. There were no
significant differences in the characteristics between the groups at
baseline or at the end of the intervention.
Dietary intake
In the HealthyDiet group, average fish consumption was 3.3 fish
meals per week (67 g per day). Mostly used fish species were
salmon, rainbow trout, vendace and Baltic herring. The average
consumption of delivered bilberries and breads was 3.2 portions
and 7.7 portions per day, respectively. The average consumption
of the delivered breads was 7.9 portions in the WGED group and
6.8 portions in the Control group per day. The average fish intake
was 42 g and 16 g per day in the WGED and in the Control
group, respectively.
At baseline, the intake of dietary fiber was higher in the
HealthyDiet group than in the WGED and Control groups (FDR
p=0.013). There were no other differences in the dietary intake at
baseline. Dietary intake is presented in Table 2. In the
HealthyDiet group, eicosapentaenoic acid (EPA), docosahexaenoic
acid (DHA) and a-linolenic acid intakes increased while in the
Control group the intake of PUFA, EPA and DHA decreased. The
decrease of SFA intake in the Healthy Diet group compared to
Control group was nearly significant (FDR p= 0.09). In the
WGED group, the intake of total fat decreased, but there was no
change in the quality of dietary fat. Fiber intake increased in both
HealthyDiet and WGED groups whereas it decreased in the
Control group.
Serum NMR metabolomics
Mixed model analyses revealed significant differences in lipid
metabolites when comparing HealthyDiet group to the Control
group (Figure 2). All changes reflected increased polyunsaturation
in plasma fatty acids. For example, ratio of bisallylic groups to
double bonds (FDR p = 361025), ratio of bisallylic groups to total
fatty acids (FDR p= 461024) and average number of double
bonds in fatty acid chain (FDR p= 0.024) increased and average
number of methylene groups per double bonds decreased (FDR
p= 0.012) in the HealthtyDiet group compared to the Control
group. Bisallylic group has chemical structure of -CH=CH-CH2-
CH=CH-, i.e. a single methylene group between the two double
bonds and it reflects the level of polyunsaturation in fatty acids.
Increases were seen especially in n-3 PUFAs, while n-6 and n-7
fatty acids decreased in the HealthyDiet group compared to the
Control group, reflecting the good compliance to fish intake
(Figure 2). The above mentioned differences existed also when
comparing HealthyDiet group to WGED group. There were no
significant changes in detected metabolites in the WGED
compared to the Control group.
There were no significant changes (FDR p , 0.05) in the
metabolic measures quantified from the LIPO- and LMWM-
windows (metabolites listed in the Supplemental table 1).
However, in within-the-group comparisons we found and
increasing trend (FDR p=0.03 – 0.08) in variables related to
large HDL particles in the HealthyDiet group (data not shown).
The changes in concentrations of large HDL particles, in average
diameter of HDL particles and in concentrations of lipid
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components of the large HDL particles associated positively with
the changes in fish intake and changes in serum n-3 fatty acids
concentrations (Table 3). When participants were divided into
tertiles according to changes in fish intake we found that
concentration of large HDL particles, mean diameter of HDL
particles and serum concentrations of the lipid components of
large HDL particles differed between these tertiles (Figure 3). The
daily intake of fish decreased in the first tertile (average change:
– 40 g/d, average intake during the intervention period: 26 g/d),
remained nearly unchanged in the second tertile (average change:
Table 2. Daily dietary intakes at baseline and during the intervention (mean 6 SD).
HealthyDiet n = 36 WGED n = 34 Control n = 35
Baseline1 Intervention2 p3 FDR p3 Baseline1 Intervention2 p3 FDR p3 Baseline1 Intervention2
Energy (kJ) 838662196 914662206 0.053 0.121 699562373 765462395 0.119 0.204 728262011 853361693
Total fat (E%) 32.566.2 30.564.6 0.064 0.129 33.665.2 31.166.3 0.012 0.043 31.365.3 31.965.9
SAFA (E%) 12.063.1 10.862.5 0.034 0.090 12.362.4 11.162.8 0.024 0.070 12.062.6 12.162.7
MUFA (E%) 10.662.6 9.561.9 0.171 0.261 11.362.1 9.862.7 0.020 0.065 10.262.4 9.962.6
PUFA (E%) 5.661.5 5.461.2 0.011 0.043 6.061.6 5.061.5 0.902 0.962 5.661.5 4.661.2
Linoleic acid (E%) 3.7861.2 3.3261.02 0.310 0.381 4.2761.39 3.3461.32 0.434 0.515 3.8361.09 3.1860.85
a-linolenic acid (E%) 0.8460.29 1.0760.28 2.06101026 2.261025 0.8960.30 0.7460.33 0.763 0.842 0.8660.40 0.7160.23
EPA 0.1560.13 0.2260.09 0.002 0.010 0.1460.24 0.1260.13 0.180 0.262 0.1060.10 0.0660.05
DHA 0.3560.28 0.5960.27 0.002 0.010 0.3060.35 0.3160.29 0.157 0.251 0.2260.24 0.1760.13
Protein (E%) 18.063.1 18.562.3 0.210 0.280 19.163.2 18.862.5 0.950 0.980 18.863.7 18.362.5
Carbohydrate (E%) 46.667.1 48.165.8 0.194 0.270 45.666.3 47.267.5 0.268 0.343 47.865.6 47.365.1
Fiber (g) 29.268.2 36.466.3 4.3610213 1.4610211 24.667.0 26.565.4 2.761027 4.361026 22.567.0 18.064.2
Sucrose (E%) 7.262.7 6.262.0 0.121 0.204 5.862.6 5.362.6 0.619 0.707 6.262.7 5.962.2
Cholesterol (mg) 2746119 2586148 0.396 0.124 2286106 2446123 0.160 0.981 2306105 2566103
Alcohol (E%) 2.964.8 3.064.8 0.659 0.838 1.662.9 3.064.5 0.203 0.435 2.164.1 2.563.2
1Based on a 4-day food record at baseline, 2Based on three 4-day food records (weeks 3, 7 and 11). 3Based on a mixed model comparison, where the interaction of time
and group compared to Controls (time*group) is analyzed.
doi:10.1371/journal.pone.0090352.t002
Figure 2. Fold changes in lipid variables at the end of the 12-week intervention period. Bars represent mean 6 SD. FDR p-values are
based on mixed model comparisons, where the interaction of time and group compared to Controls (time*group) or only the effect of time within a
group is tested. HealthyDiet n = 37, Whole grain enriched diet (WGED) n= 34 and Control n = 32.
doi:10.1371/journal.pone.0090352.g002
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+ 5 g/d, average intake: 28 g/d), and increased in the third tertile
(average change: + 62 g/d, average intake: 74 g/d). The most of
the consumed fish was fatty. Separation into tertiles based on
changes in fish intake did not correspond exactly to the separation
of intervention groups. However, most of the subjects (19 of 36) in
the third tertile were from the HealthyDiet group as could be
expected. There were no differences in changes in concentrations
of total, LDL and HDL cholesterol and Tg between the tertiles
(Figure S1).
We also tested the cross-sectional associations at baseline and at
the end of the study between mean diameters of HDL and LDL
particles and the serum Tg concentration in all participants, and
we found negative associations between the mean diameter of
HDL and serum Tg concentration (beta = –0.410, p= 1.861025
at baseline, beta = –0.320, p= 0.004 at the end), and the mean
diameter of LDL and serum Tg concentration (beta = –0.380,
p = 5.261026 at baseline, beta = –0.572, p= 3.8610210 at the
end). The associations were adjusted with BMI, age, gender and
fasting glucose concentration at baseline and BMI, age, gender,
fasting glucose concentration and intervention group at the end of
the study.
PON1 and lipid transfer protein activities
There were no significant changes in PLTP, CETP and PON1
activities during the intervention (Table 1). There was a slight
positive association between CETP and PLTP activities and the
variables related to extra-large HDL particles at baseline, but
adjusted FDR p-values were not significant (Table 4). These
associations were not seen at the end of the study. Further, we
observed no correlations between PON1 activity and HDL
particle variables at baseline or at the end of the study or between
changes in lipid transfer protein activities and changes in HDL
particle variables during the intervention period.
Discussion
In the present study the effects of diets containing fatty fish,
wholegrain and low insulin response grain products, and bilberries
on clinical characteristics, serum metabolites and lipid transfer
protein activities in persons with impaired glucose metabolism
were investigated. We found significant changes in lipid metab-
olites in the HealthyDiet group reflecting increased polyunsatura-
tion of plasma fatty acids, particularly increase in n-3 PUFAs.
Furthermore, in the within-the-group comparisons we found an
increasing trend in variables related to large HDL particles in the
HealthyDiet group, and when analysing this in more detail we
found that the increase of fish intake correlated strongly with the
increased concentration of large HDL particles, larger average
diameter of HDL particles and increased concentrations of large
HDL lipid components.
Significant changes in lipid metabolites in the HealthyDiet
group were observed. All changes reflected increased polyunsa-
turation in plasma fatty acids, especially increase in n-3 PUFAs,
while n-6 and n-7 fatty acids decreased. This is consistent with our
earlier findings of increased plasma content of long chain
polyunsaturated n-3 fatty acids and increase of plasma Tg
incorporating the long chain PUFA in the HealthyDiet group
[34]. These findings also confirm that different analytical methods
(gas chromatography, UPLC-MS and 1H-NMR), give consistent
results for comparable lipid measures. The observed changes
confirm the good compliance to the instructions of fish intake,
since the subjects in the HealthyDiet group were advised to eat
fatty fish at least three times per week, whereas subjects in the
Control group where instructed to restrict their fish intake for
maximum of 1 fish meal per week. In the WGED group, dietary
habits, besides the cereal products, were advised to keep
unchanged, which did not cause changes in the measured
metabolites.
Serum total, LDL and HDL cholesterol levels, serum Tg or
serum apoA-1 and apoB100 concentrations did not change during
the intervention. We observed that a greater increase of fish intake
was associated with increased concentration of large HDL
particles, larger average diameter of HDL particles and increased
concentrations of lipid components in large HDL particles. This is
consistent with earlier findings of increases in large HDL particles
and/or decreases of small particles after consumptions of fatty fish
or fish oil supplements [31]. The effects of n-3 PUFA on HDL
metabolism has been studied in several randomized controlled
trials, and the most of the studies suggest putative antiatherogenic
changes, with increases of large HDL particles and/or decreases of
small HDL particles [21,31]. Nearly all studies have been
conducted with fish oil supplements instead of fish consumption
Table 3. Associations1 between changes in fish intake, and changes in plasma n-3 fatty acid and DHA concentrations and changes
in concentrations of very large and large HDL particles, average diameter of HDL particles and concentrations of large HDL lipid
components in all study participants (n = 105).
Total fish 2 Fatty fish 2 n-3 fatty acids 3 DHA 3
B p FDR p B p FDR p B p FDR p B p FDR p
Concentration of very large HDL
particles 3
0.269 0.011 0.019 0.232 0.030 0.117 0.414 0.001 0.008 0.277 0.020 0.038
Concentration of large HDL particles 3 0.268 0.012 0.019 0.178 0.102 0.117 0.318 0.011 0.016 0.271 0.024 0.038
Mean diameter for HDL particles 3 0.279 0.008 0.019 0.227 0.018 0.117 0.308 0.012 0.016 0.245 0.039 0.052
Total lipids in large HDL 3 0.268 0.012 0.019 0.178 0.102 0.117 0.318 0.011 0.016 0.271 0.024 0.038
Phospholipids in large HDL 3 0.258 0.017 0.023 0.154 0.164 0.164 0.248 0.050 0.050 0.202 0.098 0.098
Total cholesterol in large HDL 3 0.228 0.029 0.033 0.197 0.064 0.117 0.349 0.004 0.011 0.319 0.006 0.024
Cholesterol esters in large HDL 3 0.198 0.057 0.057 0.187 0.077 0.117 0.345 0.004 0.011 0.335 0.004 0.024
Free cholesterol in large HDL 3 0.288 0.007 0.019 0.199 0.068 0.117 0.307 0.014 0.016 0.221 0.068 0.078
1Analysis of covariance (ANCOVA) using standardized variables. Age, BMI, gender, fasting glucose and group are included into the model, 2 Absolute change during the
intervention, (g/d), 3 Changes in plasma concentration,
doi:10.1371/journal.pone.0090352.t003
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as part of the diet. It has also been shown that EPA and DHA
supplementation improves reverse cholesterol transport (RCT)
from macrophage to feces in hamsters fed with high fat diet [47].
Our findings of larger average diameter of HDL particles and
increased concentration of large and extra-large HDL particles
within the tertile with greatest increase in fish intake are consistent
with earlier results [31]. We also observed an association between
changes in fish intake and changes in concentrations of total lipids,
phospholipids, total cholesterol, cholesterol esters and free
cholesterol in large HDL. However, based on this data we are
not able to conclude if this reflects changes in the content of large
HDL particles or only increased serum concentration of large
HDL particles. ApoA-1 and total HDL concentrations did not
change during the intervention, which may be related to the trend
of a decrease in small HDL particles (data not shown), that may
compensate increases in larger particles.
Modern genome-wide and Mendelian randomization studies
have failed to show a causal link between total HDL cholesterol
concentration and coronary artery disease [48,49], which might be
related to the fact, that HDL is a heterogenous pool of
subpopulations which differ in their structure and function [50].
In atherosclerosis-related diseases, variations in subpopulation
levels and functions are observed, supporting the general view that
the concentration of large HDL particles is inversely associated
while that of small HDL particles is positively associated with
cardiovascular disease [21,31]. In addition, Gordon et al recently
reported that the phospholipid content of large HDL subfractions
showed a significant inverse correlation with the vascular stiffness
assessed using pulse wave velocity [51]. In addition to this arterial
stiffness measurements, cholesterol efflux from human THP-1
macrophages has been shown to correlate with phospholipids and
particle mass of HDL demonstrating that the phospholipid content
of HDL is an important determinant of cholesterol efflux [52–54].
Furthermore, the effect of HDL particle size on efflux capacity,
and the impact of large HDL particles on cholesterol removal
strongly suggest their protective role against the development of
atherosclerosis [55,56]. The association between hypertriglyceri-
demia and CVD risk is also controversial and is weakened when
adjustment is made for other risk factors [48,57]. Here we found
cross-sectional negative correlations between serum Tg concen-
tration and average diameter of HDL and LDL particles, a finding
that is also evident in metabolic syndrome [58]. This suggests that
Figure 3. HDL particles and fatty fish intake. Changes in concentration of large HDL particles, mean particle diameter of HDL and serum
concentrations of large HDL lipid components (mean6 SEM) according to tertiles of changes in fish intake. Changes in fish intake are calculated from
4-d food records which were kept once at baseline and three times during the intervention period.
doi:10.1371/journal.pone.0090352.g003
Table 4. Regressions1 between CETP, PLTP activities and variables related to HDL particles at baseline.
CETP PLTP
beta p-value FDR p beta p-value FDR p n
Fasting plasma HDL cholesterol (total) 0.051 0.640 0.668 0.144 0.190 0.304 106
Mean diameter for HDL particles 0.203 0.068 0.264 0.226 0.045 0.154 103
Concentration of very large HDL particles 0.220 0.042 0.240 0.227 0.037 0.148 103
Total lipids in very large HDL 0.213 0.050 0.240 0.243 0.026 0.148 101
Total cholesterol in very large HDL 0.230 0.031 0.240 0.273 0.011 0.132 101
Cholesterol esters in very large HDL 0.234 0.029 0.240 0.297 0.006 0.132 101
Free cholesterol in very large HDL 0.238 0.026 0.240 0.230 0.033 0.148 101
Phospholipids in very large HDL 0.193 0.077 0.264 0.201 0.068 0.204 101
Triglycerides in very large HDL –0.001 0.991 0.991 0.238 0.030 0.148 103
Concentration of large HDL particles 0.102 0.363 0.484 0.163 0.150 0.285 103
Total lipids in large HDL 0.108 0.336 0.484 0.165 0.144 0.285 103
Total cholesterol in large HDL 0.119 0.282 0.484 0.171 0.125 0.285 103
Cholesterol esters in large HDL 0.107 0.334 0.484 0.175 0.115 0.285 103
Free cholesterol in large HDL 0.147 0.179 0.484 0.154 0.166 0.285 103
Phospholipids in large HDL 0.097 0.388 0.490 0.158 0.163 0.285 103
Concentration of medium HDL particles –0.103 0.344 0.484 –0.001 0.990 0.990 103
Total lipids in medium HDL –0.108 0.326 0.484 –0.012 0.912 0.990 101
Total cholesterol in medium HDL –0.121 0.259 0.484 –0.037 0.737 0.931 101
Cholesterol esters in medium HDL –0.127 0.233 0.484 –0.050 0.640 0.853 101
Free cholesterol in medium HDL –0.080 0.471 0.514 0.005 0.968 0.990 101
Phospholipids in medium HDL –0.081 0.467 0.514 0.020 0.856 0.978 101
Concentration of small HDL particles –0.108 0.280 0.484 –0.100 0.323 0.485 103
Total lipids in small HDL –0.103 0.305 0.484 –0.086 0.397 0.560 101
Triglycerides in small HDL –0.070 0.471 0.514 0.023 0.814 0.977 101
1Linear regression model; age, BMI, fasting glucose and gender included into the model.
doi:10.1371/journal.pone.0090352.t004
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the known effect of serum Tg concentration on increased risk of
CVD or type 2 diabetes may in part be related to altered HDL
metabolism [35].
The relationship between CETP and lipoprotein metabolism is
complex [59,60]. CETP is central in cholesterol and Tg transport
between HDL and apoB-containing lipoproteins in the circulation,
and this CETP-mediated lipid transfer clearly differs in various
dyslipidemias [61]. CETP simultaneously affects the concentration
and composition of both antiatherogenic and atherogenic
lipoproteins and its connection to coronary heart disease risk is
not completely understood [61]. No changes in the lipid transfer
protein activities during the 12-week dietary intervention were
observed. Earlier results of the effects of fish oil treatment on
CETP activity are discordant, which might be related to the type
of fish oil studied (EPA vs. DHA) [62,63]. We found weak positive
association between CETP and PLTP activities and mean particle
diameter of HDL and other variables related to extra-large HDL
particles at baseline. Overall, CETP can be seen as one among the
factors affecting reverse cholesterol transport pathway and high
CETP activity is reportedly associated with decreased HDL
cholesterol levels [61]. CETP inhibitors have recently gained great
interest due to their ability to increase HDL cholesterol
concentration, but it remains to be seen whether their use will
result in functionally protective HDL populations and clinical
benefit in large trials [64].
Although the effects of intervention on clinical characteristics
and measured metabolites were modest, we found a strong
association between increased fish intake and variables related to
large HDL particles. However, as a potential limitation, our study
design does not allow for total separation of fish intake from
increased intake of whole grain and low insulin response grain
products and bilberries, but this was considered in statistical
analyses by including the intervention group into the model. In
fact, not all subjects in the third tertile with the greatest increase in
fish intake were in the HealthyDiet group. The average
consumption of fish was 74 grams per day in the third tertile,
which is more than 500 g per week. This suggests that the
instructed three fish meals per week were not enough for these
changes. The mean consumption of fish in the third tertile was
more than double of average fish consumption among the Finnish
population [65]. We have seen that people who are willing to
participate in dietary interventions are more interested in healthy
eating than people in average. This phenomenon is also observed
when comparing the baseline nutrient intakes in the present study
with the respective average intakes in Finland (e.g. lower intake of
SFA and sucrose and higher intake of dietary fiber in the study
population) [65]. This is one obvious explanation why it might be
difficult to see significant changes in the intervention groups with
healthy diet. For the same reason, people in the Control group had
to limit their rye bread, fish and berry intake, so that the control
diet resembled more an average Finnish diet. For example, rye
bread intake in men in the Northern Savo area is more than
double compared to corresponding intake in Southern Finland
[65].
Besides lipoprotein subclass distribution and detailed informa-
tion on serum lipids, the NMR platform enables detection of low-
molecular-weight metabolites including e.g. citrate, acetate, urea
and amino acids. We did not see changes in these 22 measured
metabolites during the intervention. The battery of 22 low-
molecular-weight metabolites was not selected particularly for this
dietary intervention study and we did not have preliminary
hypothesis related to these metabolites. Furthermore, the power
calculation was based on fasting glucose concentration, and it is
possible that there was not enough power to see all changes in
these secondary outcome variables. Of these metabolites,
branched chain amino acids were probably the most interesting
ones, because they are related to type 2 diabetes risk and we have
earlier found that serum isoleucine decreased after the 12 week
consumption of diet high in rye bread and pasta [66,67]. Despite
similar carbohydrate modification of the diet in the HealthyDiet
and WGED groups of the present study (increasing the intakes of
rye bread and pasta), we could not see any changes in isoleucine.
This confirms our earlier conclusion that decreased isoleucine may
rather be due to decreased intake of protein rich foods, which are
also sources of isoleucine, than the intervention itself. In the
current study, there were no changes in protein intake during the
intervention period.
In conclusion, increased fatty fish intake was associated with
beneficially considered changes in HDL particles in persons at risk
for coronary heart disease. The changes which we saw in large
HDL particles could be related to those parameters that are
functionally related to reverse cholesterol transport. Thus, our
findings could partly explain the known protective effects of fish
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